Kymera Therapeutics

62nd American Society of Hematology (ASH) Virtual Annual Meeting and Exposition, December 5-8, 2020

Poster Presentation: Targeting MYD88-Mutant DLBCL with IRAKIMiDs: A Comparison to IRAK4 Kinase Inhibition and Evaluation of Synergy with Rational Combinations